# Targeted, Dose-Escalation Busulfan-Etoposide as Prep Regimen

> **NCT01048827** · PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 12 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Busulfan

## Key facts

- **NCT ID:** NCT01048827
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2013-12-31
- **Final completion:** 2015-02-25
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01048827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01048827, "Targeted, Dose-Escalation Busulfan-Etoposide as Prep Regimen". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01048827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*